Antiviral composition containing Xinjunan
A technology containing caprystrobin and a composition, applied in the field of antiviral compositions of compound A, can solve problems such as poor effectiveness and single effect, and achieve the effects of improving quality, fast efficacy and high antiviral effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0044] Embodiment 1 The preparation of 20% compound A octocalid suspension
[0045]Proportion of raw materials by weight: compound A 1%, octobinol 19%, calcium dodecylbenzenesulfonate 2%, phenethylphenol formaldehyde resin polyoxyethylene ether 3%, phenethylphenol polyoxyethylene ether 2%, naphthalenesulfonate dispersant 1%, xanthan gum 0.2%, magnesium aluminum silicate 1.5%, ethylene glycol 5%, water replenishment 100%; prepared according to the conventional production method of water suspension.
[0046] The samples of Example 1, the control drug 30% octocalid suspension (made by the laboratory) and 2% compound A suspension (made by the laboratory) were used as a comparison to carry out a drug effect comparison test.
[0047] Control object: Botrytis cinerea of tomato.
[0048]
[0049] The average temperature during medication is 21-25°C, and the weather is mainly sunny. The above data show that the compound preparation has a significantly improved anti-bacterial effe...
Embodiment 2
[0050] Embodiment 2: the preparation of 36% compound A octocalid water-dispersible granules
[0051] Raw materials by weight: 18% of compound A, 18% of octoprobin, 10% sodium methylene bis-tetrasulfonate, 7% naphthalenesulfonate formaldehyde condensate, 10% polycarboxylate, and the rest is supplemented with ammonium sulfate . Prepared according to conventional granule production methods.
[0052] The samples of Example 2, the control drug 30% octocalid WP (made by the laboratory) and 8% compound A suspension concentrate (made by the laboratory) were used as a comparison to carry out a drug effect comparison test.
[0053] Targets of control: rice thin strip disease, bacterial blight.
[0054]
[0055] The average temperature during medication is 21-25°C, and the weather is mainly sunny. The data show that the compound preparation of this example has significantly improved anti-bacterial efficiency compared with the single dose.
Embodiment 3
[0056] Example 3 Preparation of 60% compound A octocalid wettable powder
[0057] The ratio of raw materials by weight: 20% of compound A, 40% of octoprobin, 8% of sodium methylene bis-tetrasulfonate, 8% of naphthalenesulfonate formaldehyde condensate, 5% of polycarboxylate, and diatomaceous earth for the rest make up. Prepared according to conventional wettable powder production methods.
[0058] The samples of Example 3, the control drug 30% octocalid WP (made by the laboratory) and 8% compound A suspension concentrate (made by the laboratory) were used as a comparison to carry out a drug effect comparison test.
[0059] Control object: Tobacco mosaic disease.
[0060]
[0061]
[0062] The average temperature during medication is 21-25°C, and the weather is mainly sunny. The data show that the compound preparation of this example has significantly improved anti-bacterial efficiency compared with the single dose.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com